Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Med Mal Infect ; 48(6): 403-409, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29709404

RESUMEN

BACKGROUND: This study aimed to describe the microbiological epidemiology of repatriated French soldiers with an open traumatic injury, and to measure the proportion of multidrug-resistant bacteria (MDRB). METHODS: Retrospective study including all French soldiers repatriated in 2011 and 2012 in Parisian military hospitals for open traumatic injury. Results of clinical samples and MDRB screening were collected. The antibiotic susceptibility was assessed using the agar disk diffusion method. Characterization of resistance mechanisms was performed using PCR. Genotyping of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) isolates was performed using rep-PCR. RESULTS: A total of 139 patients were included; 70% of them were repatriated from Afghanistan. At admission, 24/88 were positive for MDRB (28%), mainly ESBL-E but no carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococcus faecium were identified. Forty-five patients had lesion sample collection, and 28/45 had a positive culture. The most frequently isolated pathogens were Enterobacter cloacae, Pseudomonas aeruginosa, and Escherichia coli. For eight patients, a MDRB was isolated from the wound, mainly ESBL-E (7/8) but also one methicillin-resistant Staphylococcus aureus and one imipenem-resistant Acinetobacter baumannii. Among ESBL-E, the PCR evidenced the high prevalence of CTX-M15 enzymes. Rep-PCR performed on the 23 ESBL-producing E. coli isolates highlighted numerous profiles. CONCLUSIONS: Controlling the spread of ESBL-E is currently challenging for French Armed Forces. Despite any evidence of an epidemic clone, a high-level compliance with hygiene precautions is required throughout the chain of care to avoid cross contamination.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/aislamiento & purificación , Personal Militar , Heridas Relacionadas con la Guerra/microbiología , Adulto , Enterobacteriaceae/enzimología , Enterobacteriaceae/genética , Femenino , Francia , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven , beta-Lactamasas/biosíntesis
2.
Med Mal Infect ; 48(2): 83-94, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29224715

RESUMEN

The Ebola virus disease outbreak observed in West Africa from March 2014 to June 2016 has led to many fundamental and applied research works. Knowledge of this virus has substantially increased. Treatment of many patients in epidemic countries and a few imported cases in developed countries led to developing new diagnostic methods and to adapt laboratory organization and biosafety precautions to perform conventional biological analyses. Clinical and biological monitoring of patients infected with Ebola virus disease helped to determine severity criteria and bad prognosis markers. It also contributed to showing the possibility of viral sanctuaries in patients and the risk of transmission after recovery. After a summary of recent knowledge of environmental and clinical viral persistence, we aimed to present new diagnostic methods and other biological tests that led to highlighting the pathophysiological consequences of Ebola virus disease and its prognostic markers. We also aimed to describe our lab experience in the care of Ebola virus-infected patients, especially technical and logistical changes between 2014 and 2017.


Asunto(s)
Fiebre Hemorrágica Ebola/diagnóstico , Técnicas de Laboratorio Clínico/métodos , Técnicas de Laboratorio Clínico/normas , Contención de Riesgos Biológicos/tendencias , Ebolavirus/fisiología , Francia , Fiebre Hemorrágica Ebola/prevención & control , Fiebre Hemorrágica Ebola/transmisión , Fiebre Hemorrágica Ebola/virología , Humanos , Factores de Tiempo , Virología/métodos , Virología/normas
3.
Transfus Clin Biol ; 24(1): 5-8, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27640108

RESUMEN

In December 2013, the most widespread epidemic of Ebola virus disease began in Guinea and continued for over 2 years. At the request of the Guinean state, France deployed a military field hospital to treat Ebola infected healthcare workers. From January to July 2015, our center supported 26 healthcare workers suffering from Ebola virus disease. Despite an individualized care and optimal treatment, the fatality rate remained high at 30.7%. Improved therapies are required to reduce mortality risk in Ebola virus disease. We report the case of a patient admitted to the hospital on the 4th day after onset, who survived despite several clinical and biological predictors of fatal outcome. We transfused plasma at a high dose and spread over time. This innovative therapeutic approach was based on our clinical experience of Ebola patients' management, literature review and knowledge of plasma ability to restore coagulation disorders and endotheliopathy. Even without any bleeding sign, coagulopathy and endothelial permeability disorders participate in hypovolemia and fatal multi-system organ failure. Early intake of therapeutic plasma at repeated doses seems to reduce the endothelial permeability and coagulation disorders related to Ebola virus disease.


Asunto(s)
Transfusión de Componentes Sanguíneos , Fiebre Hemorrágica Ebola/terapia , Plasma , Amidas/uso terapéutico , Antibacterianos/uso terapéutico , Conservación de la Sangre , Terapia Combinada , Manejo de la Enfermedad , Liofilización , Fármacos Gastrointestinales/uso terapéutico , Fiebre Hemorrágica Ebola/tratamiento farmacológico , Humanos , Masculino , Pirazinas/uso terapéutico , Índice de Severidad de la Enfermedad , Adulto Joven
7.
Infection ; 41(3): 705-8, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23408002

RESUMEN

We report a secondary case of rifampicin-resistant meningococcal disease and our experience in managing contact cases. Rifampicin resistance resulting from rpoB gene mutations is still uncommon enough that changing the current recommendations for chemoprophylaxis is unwarranted. However, ensuring limited but appropriate chemoprophylaxis may prevent the development of antimicrobial resistance. Thus, the definition of contact cases should be strictly respected. In the case of culture-positive Neisseria meningitidis, in vitro susceptibility testing to rifampicin must be systematically performed in order to detect rifampicin-resistant strains and, thus, institute appropriate prophylaxis in order to prevent secondary transmission.


Asunto(s)
Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana , Meningitis Meningocócica/tratamiento farmacológico , Meningitis Meningocócica/microbiología , Neisseria meningitidis/efectos de los fármacos , Rifampin/uso terapéutico , Adolescente , Antibacterianos/farmacología , Profilaxis Antibiótica/métodos , Femenino , Humanos , Meningitis Meningocócica/prevención & control , Meningitis Meningocócica/transmisión , Pruebas de Sensibilidad Microbiana , Neisseria meningitidis/aislamiento & purificación , Rifampin/farmacología
8.
Pathol Biol (Paris) ; 59(2): 97-101, 2011 Apr.
Artículo en Francés | MEDLINE | ID: mdl-20828938

RESUMEN

OBJECTIVES: The aim of this work was to evaluate the fecal carriage of third generation cephalosporins resistant Enterobacteriaceae in nonhospitalized asymptomatic young adults. METHODS: A total of 517 normal fecal samples were spread onto plates agar containing cefotaxime. Isolated strains were identified and studied with agar disk diffusion antibiogram, minimal inhibition concentration in liquid medium and phenotypic and molecular study. Data were compared with a previous study realised in the same conditions in 1999. RESULTS: In 2009, the prevalence of cefotaxime resistant enterobacteria was 4.2%. Of these 22 Enterobacteriaceae, 11 harboured overexpressed cephalosporinase and 11 produced extended-spectrum-betalactamase (ESBL). Among ESBL, six E. coli produced CTX-M from group 1 (n=6), group 2 (n=1), group 9 (n=2), one E. coli produced SHV-12 and one Klebsiella pneumoniae produced CTX-M from group 1. All ESBL were multiresistant. In 1999, all the CTX resistant isolates recovered produced a cephalosporinase and no ESBL was found. CONCLUSIONS: This study highlights the increasing prevalence of fecal carriage of ESBL-producing enterobacteria in asymptomatic young patients in the community (0% in 1999 versus 2.1% in 2009; P<0.001). E. Coli with CTX-M from group 1 was the most frequent ESBL identified, while fecal carriage of Enterobacteteriaceae overproducing cephalosporinase was similar (2.1%).


Asunto(s)
Portador Sano/microbiología , Resistencia a las Cefalosporinas , Cefalosporinasa/análisis , Infecciones por Enterobacteriaceae/microbiología , Enterobacteriaceae/aislamiento & purificación , Heces/microbiología , beta-Lactamasas/análisis , Antibacterianos/farmacología , Portador Sano/epidemiología , Cefotaxima/farmacología , Resistencia a las Cefalosporinas/genética , Cefalosporinasa/genética , ADN Bacteriano/genética , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/enzimología , Enterobacteriaceae/genética , Infecciones por Enterobacteriaceae/epidemiología , Francia/epidemiología , Humanos , Intestinos/microbiología , Personal Militar , Fenotipo , Prevalencia , Estudios Prospectivos , Adulto Joven , beta-Lactamasas/genética
9.
Ann Biol Clin (Paris) ; 67(4): 419-24, 2009.
Artículo en Francés | MEDLINE | ID: mdl-19654081

RESUMEN

Cellular morphology has a predominant place in diagnosis of hematological malignancies in spite of flow cytometry, cytogenetic and molecular biology progresses. CellaVisionDM8/96TM is automated microscope and image analysis software which are able to characterize white and red blood cells morphology and to perform platelets counts in peripheral blood smears. Validity of results is always submitted to the cytologist agreement. We routinely analyzed 99 peripheral blood smears, included 9 therapeutic cytopenias, stained with May-Grünwald-Giemsa. DM8/96TM is highly efficient in the cellular identification with great security of identity management and timesaving (30% faster than manual microscopy). Major innovations are the complete slides recording, efficiency on cytopenias processing, education functionalities and the networking ability.


Asunto(s)
Automatización/métodos , Neoplasias Hematológicas/sangre , Hematología/métodos , Autoanálisis , Células Sanguíneas/patología , Diseño de Equipo , Citometría de Flujo , Neoplasias Hematológicas/diagnóstico , Neoplasias Hematológicas/genética , Neoplasias Hematológicas/patología , Humanos , Microscopía/métodos , Biología Molecular/métodos
10.
Ann Biol Clin (Paris) ; 67(3): 333-7, 2009.
Artículo en Francés | MEDLINE | ID: mdl-19411236

RESUMEN

We present a 27-year-old soldier exertional heat stroke case report. Clinical examination has been reassuring during hospitalization. However biological disorders, especially liver and haemostasis disturbances, show off exertional heat stroke is a serious pathology on which clinician and biologist attention must be focalized, even if evolution is the more often favourable when an adapted and rapid treatment is used.


Asunto(s)
Ejercicio Físico , Golpe de Calor/fisiopatología , Esfuerzo Físico/fisiología , Adulto , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Factores de Coagulación Sanguínea/metabolismo , Fibrinógeno/metabolismo , Golpe de Calor/sangre , Golpe de Calor/etiología , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA